Involvement of the extracellular calcium in the release of elastase and the human neutrophils oxidative burst

被引:0
作者
Khalfi, F
Gressier, B
Brunet, C
Dine, T
Luyckx, M
Cazin, M
Cazin, JC
机构
[1] FAC SCI PHARMACEUT & BIOL,PHARMACOL LAB,PHARMACOCINET & PHARM CLIN,LILLE,FRANCE
[2] CTR HOSP ARMENTIERES,BIOL LAB,F-59421 ARMENTIERES,FRANCE
关键词
elastase; superoxide anion; extracellular calcium; human neutrophils; PMA; fMLP; OZ; HLE; CB;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Some proteases (particularly elastase) and metabolites of very reactive oxygen species (superoxide en peroxide, hypochlorous acid and hydroxyl radicals) are generated by polymorphonuclear neutrophils (PMNs) during inflammatory disorders. Divalent cations, especially calcium (Ca2+) play an important regulatory role in the different PMNs functions. The aim of this study is to determine the role of extracellular calcium during the liberation of elastase and of reactive oxygen species production by human PMNs. Consequently, in order to stimulate PMNs, phorbolmyristate acetate (PMA), formyl-methionyl-leucyl-phenylalanine (fMLP) and opsonized zymosan (OZ) have been used. PMNs stimulated by OZ did not release elastase to reverse the PMA and fMLP systems. The production of elastase by PMNs stimulated by PMA to reverse the fMLP system is independent from the extracellular calcium, between 0.0 and 1.5 mM. With various higher concentrations of calcium, varying from 1.5 to 4.0 mM, the release of elastase by PMNs stimulated by PMA is extracellular calcium-dependent to reverse the fMLP system. The superoxide anion (O-2(-)) generated by PMNs activated by fMLP is dependent from the extracellular calcium in the medium, whereas O-2(-) production by PMA or OZ stimulated neutrophils was extracellular calcium-independent. These observations suggest that an influx of calcium may play an important role in the production of elastase and in the capacity of PMNs stimulated by fMLP to produce O-2(-) to reverse the PMA and OZ systems.
引用
收藏
页码:1211 / 1218
页数:8
相关论文
共 21 条
[1]   ACTIVATION OF NEUTROPHIL LEUKOCYTES - CHEMOATTRACTANT RECEPTORS AND RESPIRATORY BURST [J].
BAGGIOLINI, M ;
BOULAY, F ;
BADWEY, JA ;
CURNUTTE, JT .
FASEB JOURNAL, 1993, 7 (11) :1004-1010
[2]  
BehraMiellet J, 1995, EUR J PHARM BIOPHARM, V41, P354
[3]  
BU HC, 1996, J BIOL CHEM, V271, P14308
[4]   A RAPID DENSITY GRADIENT TECHNIQUE FOR SEPARATING POLYMORPHONUCLEAR GRANULOCYTES [J].
CABANIS, A ;
GRESSIER, B ;
LEBEGUE, S ;
BRUNET, C ;
DINE, T ;
LUYCKX, M ;
CAZIN, M ;
CAZIN, JC .
APMIS, 1994, 102 (02) :119-121
[5]   SUPEROXIDE GENERATION BY DIGITONIN-STIMULATED GUINEA-PIG GRANULOCYTES - BASIS FOR A CONTINUOUS ASSAY FOR MONITORING SUPEROXIDE PRODUCTION AND FOR STUDY OF ACTIVATION OF GENERATING SYSTEM [J].
COHEN, HJ ;
CHOVANIEC, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (04) :1081-1087
[6]   THE ROLE OF C-KINASE IN THE PHYSIOLOGICAL ACTIVATION OF THE NEUTROPHIL OXIDASE - EVIDENCE FROM USING PHARMACOLOGICAL MANIPULATION OF C-KINASE ACTIVITY IN INTACT-CELLS [J].
COOKE, E ;
HALLETT, MB .
BIOCHEMICAL JOURNAL, 1985, 232 (02) :323-327
[7]   INHIBITION BY MANOALIDE OF FMLP-STIMULATED ELASTASE RELEASE FROM HUMAN NEUTROPHILS [J].
DEVRIES, GW ;
AMDAHL, LD ;
KRAMER, KD ;
WHEELER, LA .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (11) :2487-2494
[8]   INHIBITION OF HUMAN NEUTROPHIL RESPONSES BY ALPHA-CYANO-3,4-DIHYDROXYTHIOCINNAMAMIDE - A PROTEIN-TYROSINE KINASE INHIBITOR [J].
DRYDEN, P ;
DURONIO, V ;
MARTIN, L ;
HUDSON, AT ;
SALARI, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (03) :656-664
[9]   A COMPARISON OF THE PRIMING EFFECT OF PHORBOL-MYRISTATE ACETATE AND PHORBOL DIBUTYRATE ON FMET-LEU-PHE-INDUCED OXIDATIVE BURST IN HUMAN NEUTROPHILS [J].
GAUDRY, M ;
COMBADIERE, C ;
MARQUETTY, C ;
HAKIM, J .
IMMUNOPHARMACOLOGY, 1990, 20 (01) :45-56
[10]   THE EFFECT OF MESNA IN REVERSING, IN-VITRO, THE PROTEASE-ANTIPROTEASE IMBALANCE - ITS REACTION ON THE MPO-H2O2 SYSTEM AND ON HUMAN-LEUKOCYTE ELASTASE [J].
GRESSIER, B ;
LEBEGUE, S ;
BRUNET, C ;
DINE, T ;
LUYCKX, M ;
CAZIN, M ;
CAZIN, JC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 104 (02) :151-156